{
  "nctId": "NCT04338074",
  "briefTitle": "TXA and Corona Virus 2019 (COVID19) in Outpatients",
  "officialTitle": "Exploratory Studies of the Effect of Tranexamic Acid Treatment on the Progression of COVID19 in Outpatients",
  "protocolDocument": {
    "nctId": "NCT04338074",
    "filename": "Prot_SAP_003.pdf",
    "label": "Study Protocol and Statistical Analysis Plan",
    "date": "2021-05-03",
    "uploadDate": "2021-05-04T13:12",
    "size": 3516067,
    "downloadUrl": "https://clinicaltrials.gov/api/v2/studies/NCT04338074/document/Prot_SAP_003.pdf",
    "hasProtocol": true,
    "hasSap": true,
    "hasIcf": false
  },
  "phase": [
    "PHASE2"
  ],
  "studyType": "INTERVENTIONAL",
  "allocation": "RANDOMIZED",
  "interventionModel": "PARALLEL",
  "masking": "QUADRUPLE",
  "enrollmentInfo": {
    "enrollmentCount": 5,
    "enrollmentType": "ACTUAL"
  },
  "timeline": {
    "startDate": "2020-06-01",
    "completionDate": "2021-04-21",
    "primaryCompletionDate": "2021-04-21",
    "firstSubmitDate": "2020-04-06",
    "firstPostDate": "2020-04-08"
  },
  "eligibilityCriteria": {
    "criteria": "Inclusion Criteria:\n\n* Positive COVID-19 test\n* Outpatient\n* Age \\>/= 19 y.o.\n\nExclusion Criteria:\n\n* Allergic reaction to tranexamic acid\n* History of hypercoagulation disorders (deep venous thrombosis, pulmonary thromboembolism)\n* Ongoing anticoagulation\n* History of GI bleeding\n* History of Seizures\n* Cardiac or other vascular stents\n* History of severe renal disease\n* History of intracranial hemorrhage",
    "healthyVolunteers": false,
    "sex": "ALL",
    "minimumAge": "19 Years",
    "stdAges": [
      "ADULT",
      "OLDER_ADULT"
    ]
  },
  "endpoints": {
    "primary": [
      {
        "measure": "Hospitalization",
        "description": "Participant admission to hospital for COVID-19 treatment",
        "timeFrame": "Randomization to 7 days after randomization"
      }
    ],
    "secondary": [],
    "other": []
  },
  "complexityMetrics": {
    "eligibilityCriteria": {
      "inclusionCount": 1,
      "exclusionCount": 1,
      "totalCount": 2
    },
    "endpoints": {
      "primaryCount": 1,
      "secondaryCount": 0,
      "otherCount": 0,
      "totalCount": 1
    },
    "studyDesign": {
      "phases": [
        "PHASE2"
      ],
      "isRandomized": true,
      "isMasked": true,
      "interventionModel": "PARALLEL"
    },
    "overallComplexityScore": 39,
    "complexityCategory": "Moderate"
  },
  "collectionDate": "2025-09-22T02:30:39.044Z",
  "dataSource": "ClinicalTrials.gov API v2 - Comprehensive Collection"
}